임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 단계 미표기모집 예정· Venous ThromboembolismA Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
협력: 얀센(J&J)
- 2상모집 중· Cytokine Release SyndromeInfliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
협력: 얀센(J&J)
- 2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
리드: 얀센(J&J)
- 2상모집 예정· Multiple Myeloma (MM)MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
협력: 얀센(J&J)
- 1상모집 중· HealthyA Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women
리드: 얀센(J&J)
- 단계 미표기모집 중· Non-Muscle Invasive Bladder NeoplasmsA Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
리드: 얀센(J&J)
- 3상모집 중· Multiple MyelomaA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중· Colitis, UlcerativeA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Crohn DiseaseA Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 단계 미표기모집 중· Leukemia, Lymphocytic, Chronic, B-CellA Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic Leukemia
리드: 얀센(J&J)
- 1상모집 중· Hematologic NeoplasmsA Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
리드: 얀센(J&J)
- 단계 미표기모집 중· ColitisA Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorA Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Crohn DiseaseA Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중· Lupus Erythematosus, SystemicA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
리드: 얀센(J&J)
- 1/2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
리드: 얀센(J&J)
- 2상모집 중· Multiple MyelomaA Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 1상모집 중· Lymphoma, Non-HodgkinA Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
리드: 얀센(J&J)
- 2상모집 중· Dermatitis, AtopicA Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
리드: 얀센(J&J)
- 2상모집 중· Arthritis, PsoriaticA Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
리드: 얀센(J&J)
- 1상모집 중· Prostatic NeoplasmsA Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorA Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Myasthenia GravisComparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
리드: 얀센(J&J)
- 1상모집 중· Relapsed Refractory Multiple Myeloma (RRMM)Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
협력: 얀센(J&J)
- 3상모집 중· Prostatic Neoplasms, Castration-ResistantA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 얀센(J&J)
- 단계 미표기모집 중· Hemolytic Disease of the Fetus and NewbornA Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
리드: 얀센(J&J)
- 2상모집 중· Multiple Myeloma (MM)Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
협력: 얀센(J&J)
- 단계 미표기모집 중· Arthritis, PsoriaticA Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
리드: 얀센(J&J)
- 3상모집 중· Squamous Cell Carcinoma of Head and NeckA Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
리드: 얀센(J&J)
- 단계 미표기모집 중· Carcinoma, Non-Small-Cell LungA Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
리드: 얀센(J&J)
- 2상모집 중· Multiple Myeloma in RelapseSubcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
협력: 얀센(J&J)
- 1상모집 중· Acute Lymphoblastic LeukemiaA Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
리드: 얀센(J&J)
- 1상모집 중· Advanced-stage Solid TumorsA Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
리드: 얀센(J&J)
- 2/3상모집 중· Crohn DiseaseA Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 2상모집 중· Multiple MyelomaA Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
리드: 얀센(J&J)
- 3상모집 중· Colitis, UlcerativeA Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Non-Muscle Invasive Bladder NeoplasmsA Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
리드: 얀센(J&J)
- 3상모집 중· Metastatic Castration-resistant Prostate NeoplasmsA Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
리드: 얀센(J&J)
- 1상모집 중· Multiple MyelomaTalquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
협력: 얀센(J&J)
- 1상모집 중· Colorectal NeoplasmsA Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
리드: 얀센(J&J)
- 1상모집 중· Prostatic NeoplasmsA Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
리드: 얀센(J&J)
- 2상모집 중· AL AmyloidosisA Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
협력: 얀센(J&J)
- 3상모집 중· Leukemia, Myeloid, AcuteA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
리드: 얀센(J&J)
- 1/2상모집 중· Metastatic Castrate-Resistant Prostate Cancer (mCRPC)Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
협력: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
리드: 얀센(J&J)
- 1상모집 중· Leukemia, Myeloid, AcuteA Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
리드: 얀센(J&J)
- 해당없음모집 중· Cardiovascular DiseasesBEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
협력: 얀센(J&J), 노보노디스크, 화이자, 다케다
- 1상모집 중· Solid TumorsORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
협력: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, PsoriaticA Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
리드: 얀센(J&J)
- 3상모집 중· Thrombocytopenia, Neonatal AlloimmuneA Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
리드: 얀센(J&J)
- 1상모집 중단 (진행 중)· Leukemia, Myeloid, AcuteA Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
리드: 얀센(J&J)
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.